SCHEMBL6255281

SCHEMBL6255281

CC(C)(C)CCNc1nc2sc(C(N)=O)c(N)c2c(-c2cccs2)c1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.50
ALDH1A1 P00352 9/20 0.49
HPGD P15428 5/20 0.49
TDP1 Q9NUW8 2/20 0.49
HTT P42858 2/20 0.49
LMNA P02545 1/20 0.48
IKBKB O14920 3/20 0.47
LIMK1 P53667 1/20 0.45
BRAF P15056 2/20 0.44
KDM4E B2RXH2 5/20 0.44
NPSR1 Q6W5P4 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HSP90AB1 P08238 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 6/20 0.41
MEN1 O00255 5/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 7/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256632 0.88 ADORA1 (0.52) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6254259 0.86 ALDH1A1 (0.56) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6259513 0.85 ALDH1A1 (0.49) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6254870 0.83 ALDH1A1 (0.55) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6256216 0.82 ALDH1A1 (0.47) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6256654 0.81 ALDH1A1 (0.47) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6255393 0.81 ALDH1A1 (0.48) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6255123 0.80 ALDH1A1 (0.44) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6257604 0.79 ALDH1A1 (0.53) ADORA1ALDH1A1HPGDTDP1HTT
SCHEMBL6266925 0.78 ALDH1A1 (0.49) ADORA1ALDH1A1HPGDTDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005058315-A1 NOVEL HETEROCYCLIC COMPOUNDS AS IKK2 INHIBITORS WITH ANTI-HBV ACTIVITY RIBAPHARM, INC. (US) 2005-06-30 WO disclosed